» Articles » PMID: 31232084

Effects of Nutritional Status on Serum Fetuin-A Level

Overview
Date 2019 Jun 25
PMID 31232084
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Fetuin-A is a glycoprotein structured molecule which is mostly released by the liver. As a multifunctional protein, fetuin-A has positive effects on health such as calcification, cardiovascular diseases and tumor development processes with various mechanisms, whereas it plays a negative role in the processes of obesity, diabetes and fatty liver disease. There are a large number of studies reporting that serum fetuin-A levels are affected by several dietary factors. It is reported in some of these studies that several nutrients increase fetuin-A release, while some others have adverse effects. It is put forward that some nutrients such as dairy products, curcumin, niacin, palmitate, coffee and alcohol consumption decrease fetuin-A level, and dietary omega-3 fatty acids intake may increase fetuin-A concentration. In addition, it is indicated that high blood glucose levels increase hepatic fetuin-A release by activating extracellular signal-regulated kinase 1/2 enzymes and increased plasma free fatty acids do the same effect by increasing NF-B activity. Despite these studies in the literature, there is not any review evaluating fetuin-A, chronic diseases and nutrition together. Therefore, in this study, the relationship between serum fetuin levels and some diseases and the effects of nutrients on fetuin A levels were investigated with possible mechanisms.

Citing Articles

Fetal hepatocytes protect the HSPC genome via fetuin-A.

Guo X, Wang Y, Liu Y, Chu L, Zhu H, Hu Y Nature. 2024; 637(8045):402-411.

PMID: 39633051 PMC: 11711094. DOI: 10.1038/s41586-024-08307-x.


EVALUATION OF FETUIN-A LEVELS IN THE EARLY STAGE OF AUTOIMMUNE THYROIDITIS.

Sobu E, Yildiz Z, Karaaslan A, Cetin C, Akbeyaz B, Ozcora G Acta Endocrinol (Buchar). 2024; 19(3):301-306.

PMID: 38356969 PMC: 10863959. DOI: 10.4183/aeb.2023.301.


Interorgan communication with the liver: novel mechanisms and therapeutic targets.

Zhao J, Zhang X, Li Y, Yu J, Chen Z, Niu Y Front Immunol. 2023; 14:1314123.

PMID: 38155961 PMC: 10754533. DOI: 10.3389/fimmu.2023.1314123.


Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease.

Bae J, Lee B Biomedicines. 2023; 11(7).

PMID: 37509567 PMC: 10377561. DOI: 10.3390/biomedicines11071928.


Decreased plasma fetuin-A level as a novel bioindicator of poor prognosis in community-acquired pneumonia: A multi-center cohort study.

Zhao L, Shang Y, Luo Q, Ma X, Ni W, He Y Front Med (Lausanne). 2022; 9:807536.

PMID: 35966877 PMC: 9372348. DOI: 10.3389/fmed.2022.807536.